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The principles of trauma surgery have evolved during the past 20 years; from initial aggressive, deﬁnitive
management of all surgical injuries in the traumatised patient to an abbreviated laparotomy, secondary
correction of abnormal physiological parameters and then planned deﬁnitive re-exploration; the damage
control sequence.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The traditional approach to the traumatised, exsanguinated
patient was a series of standardised steps that included access,
exposure, haemostasis, resection and reconstruction,1 irre-
spective of the patient’s physiological status. Despite, a tech-
nically correct procedure the mortality of this cohort remained
high, due to prolonged operative time and persistent bleeding
leading to a lethal triad of coagulopathy, metabolic acidosis
and hypothermia. The damage control sequence evolved to
combat the physiological exhaustion engendered by the lethal
triad.
The principles of damage control surgery were ﬁrst described by
Stone et al in 1983 in an attempt to reduce mortality in exsangui-
nating patients with coagulapathy.2 They observed a 35% mortality
rate in comparison to the 98% mortality rate when using traditional
principles. The term ‘damage control surgery’ was coined by
Rotondo and Schwab3; they outlined the three stage approach to
patients with abdominal trauma, inwhich re-operation occurs after
the correction of physiological parameters.
Damage control surgery is aimed at restoring normal physiology
over restoring normal anatomy in the unstable, trauma patient. The
aim of this strategy is to facilitate surgical control of haemorrhage
and contamination, the stabilisation of potentially fatal problems atciates Ltd. Published by Elsevier Ltﬁrst look laparotomy, with secondary resuscitation followed by
scheduled deﬁnitive surgery.2. Lethal triad
First described by Burch et al,4 the lethal triad describes the
metabolic derangement of hypothermia, coagulopathy and
metabolic acidosis which leads to a ‘vicious, bloody cycle’ and
subsequent physiological exhaustion.2.1. Hypothermia
Hypothermia is a consequence of severe exsanguinating injury
and subsequent resuscitative attempts. Severe haemorrhage leads
to tissue hypoperfusion and reduced oxygen delivery, thus reducing
the body’s heat generating capacity.
Hypothermia becomes clinically signiﬁcant at temperatures
below 36 C for more than 4 h. In the multiple, injured patient it
carries a poor prognosis, with a temperature of less than 32 C
associated with a 100% mortality rate.5
Hypothermia leads to cardiac arrhythmias, reduced cardiac
output, increased systemic vascular resistance and shifting of the
oxygen-dissociation curve to the left. Furthermore, hypothermia
suppresses the immune system.
It exacerbates the lethal triad by contributing to further bleeding
due to further impairment and inhibition of coagulation factors,
due to the inactivation of the temperature-sensitive, enzyme-d. All rights reserved.
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thelial abnormalities and alterations in the ﬁbrinolytic system.6
2.2. Coagulopathy
Trauma disturbs the delicate balance between haemostatic and
ﬁbrinolytic systems, frequently leading to a state of altered
coagulation.
Every aspect of coagulation is affected in the exsanguinating,
hypothermic patient. Hypothermia leads to platelet dysfunction by
inhibiting the interaction between vonWillebrand and the platelet
glycoprotein 1b-IX-V complex.7 At temperatures of less than 35 C
there is a reduction in the metabolic rate of coagulation factors.8
Massive ﬂuid resuscitation exacerbates underlying coagulop-
athy by heamodilution and the exacerbation of an acidic environ-
ment, thus further perpetuating ongoing bleeding.
The clinical diagnosis of coagulopathic bleeding can be made by
observing generalised non-surgical bleeding from wounds, serosal
surfaces, vascular access sites and skin edges. The laboratory
diagnosis of coagulopathy is dependent on the measurement of the
prothrombin time, partial prothrombin time and ﬁbrinogen levels.
However, the usefulness of these tests is diminished in the hypo-
thermic, exsanguinating patient; therefore diagnosis must be based
on clinical judgment.
2.3. Metabolic acidosis
Prolonged hypoperfusion in the traumatised patient leads to
anaerobic metabolism and the subsequent development of lactic
acidosis.
Acidosis can depress myocardial contractility and reduces the
cardiac output. The development of a metabolic acidosis perpetu-
ates further bleeding, due to the inactivation of coagulation factors
in acidic environments.
Multiple blood transfusions, cross-clamping of the aorta and
impaired myocardial function contribute to worsening acidosis.
3. Stages of damage control surgery
3.1. Stage I: abbreviated laparotomy
An abbreviated laparotomy is directed at rapidly controlling
haemorrhage and minimising contamination.
A vertical, midline incision is made from xiphisternum to the
pubic symphysis. Once the abdominal cavity is entered immediate
control of haemorrhage and haemostasis is the main priority. This
can be achieved by four quadrant abdominal packing, ligation,
cross-clamping, shunting or balloon catheter tamponade.
Once the bleeding is controlled, the next step is the control of
contamination. The entire length of the bowel wall is inspected;
prevention of further contamination is achieved by rapid closure of
the perforated viscus by simple suturing, ligation or stapling. With
multiple enterotomies, if the area of injury represents less than 50%
of the length of the small bowel, a single resection can be under-
taken. No reconstructive surgery is undertaken at this ﬁrst
laparotomy.
Thorough irrigation of the abdominal and pelvic cavities with
warm solution should be performed prior to closure.
A plastic-covered sterile operating room towel is placed cir-
cumferentially under the fascia to cover and protect the under-
lying viscera, and the wound is packed. A small number of
central perforations are made in the covering to enable the ﬂuid
to egress to the drains. Closed-suction drains are placed above
the plastic at the level of the subcutaneous tissue brought out
through separate stab wounds or the inferior part of the woundand secured to the skin. The abdominal fascial layer is left open,
and temporary abdominal closure is undertaken with towel
clips,9 silo bag closure10 or vacuum pack.11 Skin closure is not
recommended.
3.2. Stage II: resuscitation
The second phase of damage control surgery is directed at
secondary resuscitation and restoration of physiological parame-
ters within an intensive care setting. The main aims are to
rewarm the patient, and correct the patient’s acidosis and
coagulopathy. Correction of hypothermia is of utmost importance,
as coagulopathy and acidosis can be corrected and maintained
when the body temperature is restored to normal. It may require
24–48 h to re-establish normal physiological parameters.
3.2.1. Hypothermia
Hypothermia is aggravated by heat loss from either environ-
mental factors or surgical intervention. Early termination of the
laparotomy is the ﬁrst step towards rewarming the patient. Peri-
operative management of hypothermia includes removal of all wet
clothing, increasing the ambient room temperature in the oper-
ating theatre, the use of warm resuscitation ﬂuids and ventilation
systems and temperature-regulating blankets.
The patient should be warmed to 37 C within 4 h of arrival to
the intensive care unit. If the patient’s temperature does not
respond to simple measures, and remains lower than 35 C, pleural
lavage with warm normal saline via multiple chest tubes should be
considered.3 If the core temperature remains less than 33 C then
continuous arteriovenous rewarming should be considered.
3.2.2. Coagulopathy correction
Massive transfusion requirements are anticipated to recorrect
any coagulopathy. The 10 unit rule (10 units each of red blood
cells (RBCs), fresh frozen plasma (FFP) and platelets) should
serve as a transfusion guide within the ﬁrst 24 h. The adminis-
tration of blood products should be continued until the
prothrombin time is less than 15 s and platelet counts are
greater than 100,000/mm3. Cryoprecipitate is administered when
ﬁbrinogen levels are less than 100 mg/dL and should be given
every 4 h until the ﬁbrinogen level is greater than 100 mg/dL.12
Recombinant factor VIIa should be considered in life-threatening,
non-surgical haemorrhage.13
3.2.3. Correction of acidosis
The patient’s metabolic acidosis recorrects itself with adequate
resuscitation and rewarming. Once the oxygen debt is repaid the
body switches from anaerobic to aerobic metabolism.3.3. Stage III: deﬁnitive surgery
Planned re-operation occurs after a window period of 36–48 h
between the initial insult and correction of the metabolic disorder.
Abdominal packing is removed. A complete laparotomy is per-
formed to look for any hidden injuries.
This is the phase of management whereby deﬁnitive procedures
are undertaken; gastrointestinal continuity is restored and vascular
repair is undertaken. Provision for enteral feeding is made by either
the transabdominal route or naso-enteric route, which is followed
by washout of the abdominal cavity and an attempt at deﬁnitive
closure.
Occasionally, a return to the theatre is unplanned in the event of
persistent ongoing bleeding, the development of abdominal
compartment syndrome, persistent lactic acidosis or peritonitis.
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Prompt identiﬁcation of candidates and recognition of the
deranged physiological parameters necessary for the initiation of
damage control procedures are of paramount importance to its
success.
Asenio et al were the ﬁrst to describe clinical intra-operative
parameters for the initiation of the principles of damage control, in
a series of 548 patients, mean admission pH 7.15, mean intra-
operative temperature 34.3, and these patients received an average
of 14,165 mL of crystalloid, blood and blood products.14 On the basis
of these ﬁndings, objective intra-operative parameters were
developed to predict outcome and provide guidelines on when to
initiate damage control (Fig. 1).
In addition to the physiological parameters, the principles of
damage control should be initiated in high-energy, blunt torso
trauma; multiple torso penetrations; haemodynamic instability;
and coagulopathy and/or hypothermia on admission.
Certain complexes of injuries may predict the need for damage
control surgery. These include major abdominal vascular, complex
hepatic and major thoracic vascular injuries and the need for intra-
operative thoracotomy.155. Complications of damage control surgery
5.1. Abdominal compartment syndrome
Compartment syndrome is deﬁned as increased pressure within
a conﬁned space leading to the subsequent impairment of tissue
within that space. Abdominal compartment syndrome (ACS) occurs
in abdominal trauma accompanied by visceral swelling, haema-
toma and abdominal packing.
ACS can be recognised by the presence of a tensely distended
abdomen, elevated peak airway pressures, inadequate ventilation,
hypoxia and oliguria or anuria. The clinical diagnosis can bePhysiological Guidelines
Hypothermia < 34°C
Acidosis pH <7.2
Serum Bicarbonate <15mEq/l
Transfusion of > 4000ml/l
Transfusion of >5000ml and blood products
Intraoperative volume replacement >12000ml
Clinical evidence of intraoperative coagulopathy
Fig. 1. Intra-operative parameters for the initiation of damage control.conﬁrmed by measurement of the intra-abdominal pressure, via
either a 3-way Foley catheter in the bladder or a Ryle’s tube in the
stomach attached to a water manometer. Normal intra-abdominal
pressure is 0 cm of H20. Pressure over 35 cm of H20 is diagnostic.
16
As the intra-abdominal pressure rises, progressive organ failure
occurs, with the kidneys and lungs most affected. Intra-abdominal
pressures of 15–20 mmHg lead to oliguria, with anuria ensuing at
pressures exceeding 30 mmHg. Thoracic volume and compliance
are affected due to diaphragmatic splinting from abdominal
distension, leading to compressive atelectasis and a ventilation-
perfusion mismatch. Respiratory failure occurs at an intra-
abdominal pressure of 35 mmHg,17which is promptly reversedwith
decompression. Increased intra-abdominal pressure reduces
venous return, which leads to a reduced cardiac output and an
increase in systemic vascular resistance. The central nervous
system is also affected due to increased intracranial pressure
secondary to raised central venous pressure.
Management is by immediate abdominal decompression;
however this may lead to the potentially lethal reperfusion
syndrome.185.2. General complications
These patients are at a higher risk of post-operative complica-
tions. Wound sepsis and wound dehiscence are common in this
cohort of patients due to the high contamination load. Risk of ﬁstula
formation is high in an open abdomen, pancreatic injury or bowel
injury.6. Conclusion
The damage control sequence represents an evolving attitude in
the management of trauma patients, with the focus being on
physiological optimisation prior to anatomical repair and restora-
tion. This has led to improved survival rates in the severely trau-
matised, exsanguinating patients due to the timely management of
the lethal triad of hypothermia, coagulopathy and metabolic
acidosis.Conﬂict of interest
None declared.References
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